FDA
approval
· 2021-03-04
FDA Approved: BUPRENORPHINE HYDROCHLORIDE — Supplemental Application (Advagen Pharma Ltd)
Summary
FDA approved a supplemental application for buprenorphine hydrochloride filed by Advagen Pharma Ltd under the ANDA, authorizing changes to the approved product.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BUPRENORPHINE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE)